The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCELERON PHARMA INC | COM | 00434H108 | 47,224 | 1,553,937 | SH | SOLE | 1,553,937 | 0 | 0 | ||
| AKEBIA THERAPEUTICS INC | COM | 00972D105 | 26,071 | 1,814,289 | SH | SOLE | 1,814,289 | 0 | 0 | ||
| ANAPTYSBIO INC | COM | 032724106 | 72,592 | 3,033,504 | SH | SOLE | 3,033,504 | 0 | 0 | ||
| APOLLO ENDOSURGERY INC | COM | 03767D108 | 10,667 | 1,351,972 | SH | SOLE | 1,351,972 | 0 | 0 | ||
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | 39,253 | 3,244,046 | SH | SOLE | 3,244,046 | 0 | 0 | ||
| CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 3,578 | 223,317 | SH | SOLE | 223,317 | 0 | 0 | ||
| DERMIRA INC | COM | 24983L104 | 44,720 | 1,534,664 | SH | SOLE | 1,534,664 | 0 | 0 | ||
| FLEXION THERAPEUTICS INC | COM | 33938J106 | 30,330 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| HTG MOLECULAR DIAGNOSTICS INC | COM | 40434H104 | 3,273 | 1,230,399 | SH | SOLE | 1,230,399 | 0 | 0 | ||
| INOGEN INC | COM | 45780L104 | 338,676 | 3,549,320 | SH | SOLE | 3,549,320 | 0 | 0 | ||
| INVUITY INC | COM NEW | 46187J205 | 9,888 | 1,363,848 | SH | SOLE | 1,363,848 | 0 | 0 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 21,358 | 2,901,927 | SH | SOLE | 2,901,927 | 0 | 0 | ||
| MERUS N V | COM | N5749R100 | 22,355 | 1,410,417 | SH | SOLE | 1,410,417 | 0 | 0 | ||
| NABRIVA THERAPEUTICS PLC | SHS | G63637105 | 24,382 | 2,326,544 | SH | SOLE | 2,326,544 | 0 | 0 | ||
| OBSEVA SA | COM | H5861P103 | 23,177 | 2,710,760 | SH | SOLE | 2,710,760 | 0 | 0 | ||
| RA PHARMACEUTICALS INC | COM | 74933V108 | 38,071 | 2,031,562 | SH | SOLE | 2,031,562 | 0 | 0 | ||
| REATA PHARMACEUTICALS INC | CL A | 75615P103 | 18,756 | 592,794 | SH | SOLE | 592,794 | 0 | 0 | ||
| SPECTRANETICS CORP | COM | 84760C107 | 45,616 | 1,187,917 | SH | SOLE | 1,187,917 | 0 | 0 | ||
| VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 8,637 | 740,740 | SH | SOLE | 740,740 | 0 | 0 | ||
| WRIGHT MED GROUP N V | RIGHT 03/01/2019 | N96617126 | 6,748 | 4,622,032 | PRN | SOLE | 0 | 0 | 4,622,032 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 402 | 127,563 | SH | SOLE | 127,563 | 0 | 0 | ||